US drug approval ignores science's subtleties, experts say
Article Abstract:
A US Food and Drug Administration (FDA) advisory panel in March 2006 decided unanimously to allow the drug, Tysabri, back on the market with some restrictions based on a two-day meeting in which people who had benefited from the drug tearfully testified the treatment as their only hope. Tysabri was launched in November 2004 but withdrawn three months later by the drug makers after discovering that a rare brain infection called progressive multifocal leukoencephalopathy struck two people and killed one.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
The body snatchers
Article Abstract:
The increasing demand for human tissues, required for education, transplant and research, is giving rise to a flourishing underground market for human body parts, state observers. A discussion on the illegal tissue trade, the loopholes in the law that allow it to continue, and some suggestions on how researchers can ensure transparency in the process of acquiring cadavers is presented.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Pricey cancer genome project struggles with sample shortage
Article Abstract:
The Cancer Genome Atlas Project came into existence in December 2005 to examine different types of tumors and develop treatments for the same. Although the project costs more than $100 million, it has not been able to meet the target of collecting 50,000 samples of more than hundred types of cancers.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Stem cells may offer incontinence cure. Primary care takes the lead in health. The next nursing century
- Abstracts: Using post-take ward rounds to facilitate simple discharge. Pre-op scheme reduces patient stays. Moving policy from board to ward
- Abstracts: High prevalence of lesser-known STDs. Epidurals' benefit for back pain questioned. Efficacy still uncertain for widely used supplements for arthritis